Skip to content
Disclosery

Eversept Partners, LP

Follow

13F filer, CIK 1697013, NEW YORK, NY

Eversept Partners, LP reported $1,896,429,938 across 120 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 52.57% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697013-26-000003

Period
2026-03-31
Reported value
$1.9B
Holdings
120
Top 10 weight
52.57%
New
44
Sold out
31

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BKDadded+3,193,626$43.7M
WELLnew+180,953$35.8M
DOCnew+1,981,070$32.5M
ABVXadded+276,589$30.8M
OHInew+585,680$25.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GSKreduced-894,546-$49.4M
DHRexited-186,262-$42.6M
VERAreduced-899,018-$36.2M
EXASexited-241,678-$24.5M
BRKRreduced-666,776-$24.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001697013-26-000003, largest first. % of portfolio is the value over $1,517,449,156, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 130,949 shares; 2024Q4: 43,703 shares; 2025Q1: 57,489 shares; 2025Q2: 59,366 shares; 2025Q3: 253,220 shares; 2025Q4: 252,592 shares; 2026Q1: 264,271 shares 264,271$157M10.33%+11,679Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 426,499 shares; 2025Q4: 657,834 shares; 2026Q1: 934,423 shares 934,423$104M6.86%+276,589Timeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,057,206 shares; 2024Q4: 3,661,768 shares; 2025Q1: 2,623,246 shares; 2025Q2: 2,242,388 shares; 2025Q3: 2,120,446 shares; 2025Q4: 2,679,721 shares; 2026Q1: 1,785,175 shares 1,785,175$98.5M6.49%-894,546Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,050,157 shares; 2024Q4: 1,600,015 shares; 2025Q1: 1,898,804 shares; 2025Q2: 2,383,055 shares; 2025Q3: 2,807,836 shares; 2025Q4: 3,072,304 shares; 2026Q1: 2,173,286 shares 2,173,286$87.4M5.76%-899,018Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 870,193 shares; 2024Q4: 876,766 shares; 2025Q1: 893,721 shares; 2025Q2: 796,375 shares; 2025Q3: 519,644 shares; 2025Q4: 334,493 shares; 2026Q1: 384,713 shares 384,713$76.9M5.07%+50,220Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,105,313 shares; 2024Q4: 343,400 shares; 2025Q1: 4,212,270 shares; 2025Q2: 4,065,355 shares; 2025Q3: 3,467,314 shares; 2025Q4: 3,314,408 shares; 2026Q1: 2,885,622 shares 2,885,622$67.4M4.44%-428,786Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 564,902 shares; 2024Q4: 719,836 shares; 2025Q1: 696,499 shares; 2025Q2: 838,736 shares; 2025Q3: 1,153,920 shares; 2025Q4: 1,434,725 shares; 2026Q1: 1,788,016 shares 1,788,016$56.7M3.74%+353,291Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 127,588 shares; 2025Q1: 557,070 shares; 2025Q2: 1,298,514 shares; 2025Q3: 1,421,983 shares; 2025Q4: 1,197,722 shares; 2026Q1: 924,193 shares 924,193$53.7M3.54%-273,529Timeline
BKDBROOKDALE SR LIVING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 861,268 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 374,929 shares; 2026Q1: 3,568,555 shares 3,568,555$48.8M3.22%+3,193,626Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 471,355 shares; 2024Q4: 214,952 shares; 2025Q1: 517,021 shares; 2025Q2: 588,900 shares; 2025Q3: 538,661 shares; 2025Q4: 538,218 shares; 2026Q1: 632,100 shares 632,100$47.5M3.13%+93,882Timeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 129,084 shares; 2024Q4: 175,808 shares; 2025Q1: 152,502 shares; 2025Q2: 99,983 shares; 2025Q3: 111,700 shares; 2025Q4: 95,874 shares; 2026Q1: 79,229 shares 79,229$37.5M2.47%-16,645Timeline
WELLWELLTOWER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 180,953 shares 180,953$35.8M2.36%newTimeline
DOCHEALTHPEAK PROPERTIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,981,070 shares 1,981,070$32.5M2.14%newTimeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 45,604 shares; 2025Q4: 74,708 shares; 2026Q1: 143,546 shares 143,546$30.1M1.99%+68,838Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 535,405 shares; 2024Q4: 1,980,312 shares; 2025Q1: 2,172,436 shares; 2025Q2: 1,207,638 shares; 2025Q3: 1,373,625 shares; 2025Q4: 2,992,895 shares; 2026Q1: 3,039,820 shares 3,039,820$28.9M1.91%+46,925Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,320,174 shares; 2025Q3: 12,599,002 shares; 2025Q4: 17,659,983 shares; 2026Q1: 18,834,883 shares 18,834,883$28.1M1.85%+1,174,900Timeline
OHIOMEGA HEALTHCARE INVS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 585,680 shares 585,680$25.7M1.69%newTimeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 137,949 shares; 2024Q4: 571,305 shares; 2025Q1: 150,480 shares; 2025Q2: 358,828 shares; 2025Q3: 486,021 shares; 2025Q4: 509,443 shares; 2026Q1: 677,392 shares 677,392$25.6M1.68%+167,949Timeline
CYHCOMMUNITY HEALTH SYS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,776,455 shares; 2024Q4: 2,827,000 shares; 2025Q1: 8,458,020 shares; 2025Q2: 6,144,384 shares; 2025Q3: 6,950,051 shares; 2025Q4: 7,943,802 shares; 2026Q1: 8,677,281 shares 8,677,281$25.5M1.68%+733,479Timeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 168,369 shares; 2024Q4: 168,369 shares; 2025Q1: 122,823 shares; 2025Q2: 1,526,164 shares; 2025Q3: 924,442 shares; 2025Q4: 3,176,644 shares; 2026Q1: 2,974,287 shares 2,974,287$23.3M1.54%-202,357Timeline
QGENQIAGEN NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 545,330 shares 545,330$21.8M1.44%newTimeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,926 shares; 2026Q1: 194,104 shares 194,104$18.8M1.24%+87,178Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,623 shares; 2026Q1: 19,000 shares 19,000$17.5M1.15%+8,377Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 869,913 shares; 2024Q4: 490,296 shares; 2025Q1: 816,254 shares; 2025Q2: 1,315,033 shares; 2025Q3: 1,417,204 shares; 2025Q4: 1,174,968 shares; 2026Q1: 542,610 shares 542,610$16.1M1.06%-632,358Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,507,090 shares; 2026Q1: 3,188,514 shares 3,188,514$15M0.99%+681,424Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 163,593 shares; 2024Q4: 54,066 shares; 2025Q1: 18,452 shares; 2025Q2: 18,620 shares; 2025Q3: 105,087 shares; 2025Q4: not reported; 2026Q1: 120,785 shares 120,785$14.2M0.94%newTimeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 678,262 shares; 2026Q1: 1,414,838 shares 1,414,838$14.2M0.93%+736,576Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 691,232 shares; 2024Q4: 779,998 shares; 2025Q1: 1,377,674 shares; 2025Q2: 1,902,539 shares; 2025Q3: 1,924,306 shares; 2025Q4: 1,782,235 shares; 2026Q1: 713,269 shares 713,269$14M0.92%-1,068,966Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 693,263 shares; 2024Q4: 191,158 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 111,466 shares; 2025Q4: 434,634 shares; 2026Q1: 576,580 shares 576,580$13.6M0.9%+141,946Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,429,377 shares; 2025Q4: 1,715,129 shares; 2026Q1: 2,229,446 shares 2,229,446$13.4M0.88%+514,317Timeline
LTCLTC PPTYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 321,046 shares 321,046$11.9M0.79%newTimeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 146,642 shares; 2025Q4: 93,748 shares; 2026Q1: 207,768 shares 207,768$11.7M0.77%+114,020Timeline
CHECHEMED CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 31,057 shares 31,057$11.7M0.77%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 439,177 shares; 2026Q1: 406,960 shares 406,960$11.5M0.76%-32,217Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,980 shares; 2025Q3: 37,980 shares; 2025Q4: 293,960 shares; 2026Q1: 312,178 shares 312,178$9.52M0.63%+18,218Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 307,357 shares; 2024Q4: 275,362 shares; 2025Q1: 280,951 shares; 2025Q2: 414,430 shares; 2025Q3: 488,592 shares; 2025Q4: 420,827 shares; 2026Q1: 285,764 shares 285,764$9.15M0.6%-135,063Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,391,548 shares; 2026Q1: 4,987,499 shares 4,987,499$8.73M0.58%-404,049Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 267,823 shares; 2026Q1: 159,708 shares 159,708$8.11M0.53%-108,115Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 239,110 shares 239,110$7.78M0.51%newTimeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 13,668 shares; 2024Q4: 19,252 shares; 2025Q1: 10,840 shares; 2025Q2: 64,587 shares; 2025Q3: 55,025 shares; 2025Q4: 95,832 shares; 2026Q1: 68,688 shares 68,688$7.6M0.5%-27,144Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 155,540 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 231,380 shares; 2026Q1: 129,574 shares 129,574$7.53M0.5%-101,806Timeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 469,692 shares; 2024Q4: 392,518 shares; 2025Q1: 299,087 shares; 2025Q2: 510,330 shares; 2025Q3: 394,311 shares; 2025Q4: 162,777 shares; 2026Q1: 84,854 shares 84,854$7.43M0.49%-77,923Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares 200,000$6.77M0.45%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 99,338 shares; 2025Q3: 166,391 shares; 2025Q4: 127,561 shares; 2026Q1: 138,036 shares 138,036$6.65M0.44%+10,475Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 663,573 shares; 2024Q4: 299,310 shares; 2025Q1: 280,117 shares; 2025Q2: 394,139 shares; 2025Q3: 591,540 shares; 2025Q4: 377,405 shares; 2026Q1: 125,896 shares 125,896$6.58M0.43%-251,509Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 158,957 shares; 2025Q2: 31,496 shares; 2025Q3: not reported; 2025Q4: 147,471 shares; 2026Q1: 60,214 shares 60,214$6.48M0.43%-87,257Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 29,512 shares 29,512$5.57M0.37%newTimeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares 10,000$5.23M0.34%newTimeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,426 shares; 2025Q4: 18,062 shares; 2026Q1: 11,119 shares 11,119$5.13M0.34%-6,943Timeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,851,133 shares; 2026Q1: 1,735,963 shares 1,735,963$4.76M0.31%-2,115,170Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,588 shares; 2024Q4: not reported; 2025Q1: 23,735 shares; 2025Q2: 20,600 shares; 2025Q3: 9,470 shares; 2025Q4: 45,470 shares; 2026Q1: 32,811 shares 32,811$4.37M0.29%-12,659Timeline
HQYHEALTHEQUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 319,078 shares; 2024Q4: 386,697 shares; 2025Q1: 351,976 shares; 2025Q2: 155,868 shares; 2025Q3: 52,388 shares; 2025Q4: 185,739 shares; 2026Q1: 51,614 shares 51,614$4.31M0.28%-134,125Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 234,934 shares; 2025Q1: 499,207 shares; 2025Q2: 839,284 shares; 2025Q3: 687,129 shares; 2025Q4: 783,789 shares; 2026Q1: 117,013 shares 117,013$4.23M0.28%-666,776Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 183,902 shares 183,902$3.94M0.26%newTimeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 677,924 shares 677,924$3.75M0.25%newTimeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 134,959 shares; 2024Q4: 188,493 shares; 2025Q1: 340,339 shares; 2025Q2: 398,726 shares; 2025Q3: 224,550 shares; 2025Q4: 324,092 shares; 2026Q1: 111,652 shares 111,652$3.66M0.24%-212,440Timeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 756,600 shares 756,600$3.5M0.23%newTimeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 455,835 shares; 2026Q1: 510,543 shares 510,543$3.48M0.23%+54,708Timeline
EHABENHABIT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 218,510 shares; 2026Q1: 227,451 shares 227,451$3.2M0.21%+8,941Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 160,723 shares 160,723$3.04M0.2%newTimeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,498,993 shares 1,498,993$3M0.2%newTimeline
ENSGENSIGN GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 14,761 shares 14,761$2.97M0.2%newTimeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,047,265 shares; 2025Q4: 2,140,130 shares; 2026Q1: 2,276,349 shares 2,276,349$2.96M0.2%+136,219Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,348,360 shares 2,348,360$2.91M0.19%newTimeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 332,756 shares; 2024Q4: 200,095 shares; 2025Q1: 617,418 shares; 2025Q2: 1,986,072 shares; 2025Q3: 1,488,725 shares; 2025Q4: 1,006,163 shares; 2026Q1: 1,351,106 shares 1,351,106$2.9M0.19%+344,943Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 125,168 shares 125,168$2.81M0.19%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 533,409 shares; 2025Q3: 479,056 shares; 2025Q4: 489,137 shares; 2026Q1: 270,705 shares 270,705$2.69M0.18%-218,432Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,992 shares; 2025Q4: not reported; 2026Q1: 334,861 shares 334,861$2.56M0.17%newTimeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,198 shares 100,198$2.47M0.16%newTimeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 294,989 shares 294,989$2.36M0.16%newTimeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares 250,000$2.24M0.15%newTimeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 401,187 shares 401,187$2.23M0.15%-98,813Timeline
AMRNAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 167,276 shares; 2025Q3: 167,276 shares; 2025Q4: 172,188 shares; 2026Q1: 147,715 shares 147,715$2.14M0.14%-24,473Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 170,195 shares; 2026Q1: 384,264 shares 384,264$2.1M0.14%+214,069Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 277,899 shares 277,899$1.93M0.13%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 134,619 shares; 2025Q4: 137,493 shares; 2026Q1: 146,411 shares 146,411$1.91M0.13%+8,918Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 193,571 shares; 2026Q1: 73,161 shares 73,161$1.82M0.12%-120,410Timeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,035,360 shares 1,035,360$1.8M0.12%newTimeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 76,997 shares; 2025Q4: 95,286 shares; 2026Q1: 58,624 shares 58,624$1.71M0.11%-36,662Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,621,787 shares; 2024Q4: 492,452 shares; 2025Q1: 1,675,978 shares; 2025Q2: 1,640,430 shares; 2025Q3: 1,730,635 shares; 2025Q4: 1,757,312 shares; 2026Q1: 1,758,573 shares 1,758,573$1.57M0.1%+1,261Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 257,154 shares; 2025Q2: 257,154 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 276,174 shares 276,174$1.54M0.1%newTimeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 120,927 shares; 2026Q1: 27,089 shares 27,089$1.5M0.1%-93,838Timeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 120,978 shares; 2026Q1: 134,917 shares 134,917$1.47M0.1%+13,939Timeline
BVSBIOVENTUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 433,933 shares; 2025Q4: 471,257 shares; 2026Q1: 159,110 shares 159,110$1.45M0.1%-312,147Timeline
AGLAGILON HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 176,588 shares 176,588$1.4M0.09%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 317,182 shares; 2026Q1: 62,575 shares 62,575$1.31M0.09%-254,607Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 54,680 shares 54,680$1.26M0.08%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 39,238 shares 39,238$1.18M0.08%newTimeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 159,676 shares; 2026Q1: 40,889 shares 40,889$1.13M0.07%-118,787Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 824,594 shares; 2025Q4: 842,023 shares; 2026Q1: 891,425 shares 891,425$1.12M0.07%+49,402Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 976,511 shares; 2025Q4: 251,593 shares; 2026Q1: 136,235 shares 136,235$1.09M0.07%-115,358Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 260,259 shares; 2026Q1: 306,800 shares 306,800$1.06M0.07%+46,541Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 272,706 shares; 2025Q4: 278,564 shares; 2026Q1: 27,055 shares 27,055$1.04M0.07%-251,509Timeline
PASGPASSAGE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 126,230 shares; 2026Q1: 131,581 shares 131,581$1.03M0.07%+5,351Timeline
DHCDIVERSIFIED HEALTHCARE TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 151,283 shares 151,283$1M0.07%newTimeline
INMDINMODE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 61,938 shares; 2026Q1: 67,744 shares 67,744$927K0.06%+5,806Timeline
SNDASONIDA SENIOR LIVING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,437 shares 28,437$917K0.06%newTimeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 211,469 shares; 2025Q3: 194,440 shares; 2025Q4: 178,915 shares; 2026Q1: 190,715 shares 190,715$885K0.06%+11,800Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 290,919 shares; 2026Q1: 290,919 shares 290,919$719K0.05%0Timeline
SSIISS INNOVATIONS INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,358 shares; 2026Q1: 110,157 shares 110,157$551K0.04%+34,799Timeline
RVPRETRACTABLE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 363,315 shares; 2025Q4: 580,919 shares; 2026Q1: 580,919 shares 580,919$384K0.03%0Timeline
EHTHEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 89,220 shares; 2025Q2: 128,322 shares; 2025Q3: 128,322 shares; 2025Q4: 222,570 shares; 2026Q1: 220,915 shares 220,915$285K0.02%-1,655Timeline
SLQTSELECTQUOTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 357,661 shares; 2026Q1: 357,661 shares 357,661$225K0.01%0Timeline
AIRSAIRSCULPT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 74,139 shares 74,139$210K0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QQQINVESCO QQQ TR COMput238,700$138M+13,700
SPYSTATE STR SPDR S&P 500 ETF T SHSput107,000$69.6M+62,100
VRTXVERTEX PHARMACEUTICALS INC COMcall90,000$40.2Mnew
TLTISHARES TR 20 YR TR BD ETFput428,800$37.2M+198,800
QGENQIAGEN NV Stockcall476,300$19.1Mnew
INSMINSMED INC Stockcall94,000$15.4Mnew
HYGISHARES TR IBOXX HI YD ETFput180,000$14.3Mnew
UNHUNITEDHEALTH GROUP INC COMcall40,000$10.8Mnew
IWMISHARES TR SHSput40,000$9.92Mnew
XLKSELECT SECTOR SPDR TR SHSput70,000$9.3Mnew
PRAXPRAXIS PRECISION MEDICINES I COM NEWput14,800$4.77Mnew
XBISPDR SERIES TRUST S&P BIOTECHput30,000$3.83M-69,400
UHSUNIVERSAL HLTH SVCS INC Stockput18,200$3.26Mnew
XLESELECT SECTOR SPDR TR SHScall50,000$3.06Mnew
REPLREPLIMUNE GROUP INC COMMON STOCKcall52,000$398Knew
KPTIKARYOPHARM THERAPEUTICS INC COMMON STOCKcall23,800$133Knew

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DHRDANAHER CORP DEL186,262$42.6Mshares
EXASEXACT SCIENCES CORP241,678$24.5Mshares
CDTXCIDARA THERAPEUTICS INC98,721$21.8Mshares
TEVATEVA PHARMACEUTICAL INDS LTD660,177$20.6Mshares
UNHUNITEDHEALTH GROUP INC60,862$20.1Mshares
BIIBBIOGEN INC77,944$13.7Mshares
SEMSELECT MED HLDGS CORP906,100$13.5Mshares
CGONCG ONCOLOGY INC308,466$12.8Mshares
BMYBRISTOL-MYERS SQUIBB CO235,293$12.7Mshares
ELVELEVANCE HEALTH INC FORMERLY30,195$10.6Mshares
MNKDMANNKIND CORP1,852,563$10.5Mshares
ASNDASCENDIS PHARMA A/S48,241$10.3Mshares
ILMNILLUMINA INC76,721$10.1Mshares
DVAXDYNAVAX TECHNOLOGIES CORP605,976$9.32Mshares
EWTXEDGEWISE THERAPEUTICS INC337,340$8.37Mshares
CPRXCATALYST PHARMACEUTICALS INC358,168$8.36Mshares
HUMHUMANA INC32,462$8.31Mshares
REGNREGENERON PHARMACEUTICALS10,097$7.79Mshares
CVSCVS HEALTH CORP63,696$5.05Mshares
ACADACADIA PHARMACEUTICALS INC176,594$4.72Mshares
PTGXPROTAGONIST THERAPEUTICS INC52,961$4.63Mshares
ZBIOZENAS BIOPHARMA INC121,016$4.39Mshares
NHCNATIONAL HEALTHCARE CORP28,577$3.92Mshares
FTREFORTREA HLDGS INC224,139$3.87Mshares
MRVIMARAVAI LIFESCIENCES HLDGS I718,582$2.34Mshares
EOLSEVOLUS INC344,104$2.29Mshares
RAPPRAPPORT THERAPEUTICS INC59,233$1.8Mshares
BHVNBIOHAVEN LTD145,431$1.64Mshares
QUREUNIQURE NV62,820$1.5Mshares
NVAXNOVAVAX INC181,220$1.22Mshares
CBLLCERIBELL INC17,094$375Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001697013-26-000003 base2026-05-15acceptance time not in the bulk data set